How do GLP-1 Receptor Agonists Affect the Pancreas?
The pancreas is a primary site of action for GLP-1 receptor agonists, given their role in stimulating insulin secretion. While the drugs are designed to enhance pancreatic function, there is concern about their long-term effects on pancreatic tissue. Monitoring pancreatic enzymes and regular follow-up can help mitigate potential risks, but the exact mechanisms by which GLP-1 RAs might contribute to pancreatic pathology remain an area of active research.
